Skip to main content
Open source · MIT Licensed

Open-source AI-powered
drug design platform

From protein target to druggable pocket to molecular prediction — in minutes, not months. Built on AlphaFold 3, P2Rank, and the latest open-source computational biology tools.

OpenDDE — EGFR (P00533)
OpenDDE target explorer — EGFR (P00533) with 22 druggable pockets

Built with leading open-source tools

AlphaFold 3P2RankChEMBLImmuneBuilderRDKitOpenTargets
0M+
Protein structures
in AlphaFold DB
0
AI-powered
prediction engines
0+
Known drug
databases integrated
100%
Open source
MIT license

The Challenge

Developing a new drug takes 10–15 years and costs $2.6 billion

Target ID
2-3 yrs
Hit Finding
1-2 yrs
Lead Optimization
1-2 yrs
Preclinical
1 yr
Phase I
1-2 yrs
Phase II
2-3 yrs
Phase III
3-4 yrs
Approval
1-2 yrs
OpenDDE accelerates these stages

Only 12% of drugs that enter clinical trials are eventually approved.

OpenDDE accelerates the earliest stages — target validation, pocket discovery, and hit identification — where computational tools can save years of experimental work.

Drug Discovery 101

How drug discovery works

Understanding the journey from disease biology to approved medicine.

1

Identify the target

Every disease is caused by specific proteins malfunctioning in the body. The first step is identifying which protein to target — like finding which broken part of an engine to fix.

2

Find the binding pocket

Proteins have specific pockets on their surface where small molecules can bind, like a key fitting into a lock. Finding these pockets is critical — you need to know WHERE on the protein a drug can attach.

OpenDDE: P2Rank pocket prediction
3

Discover candidate molecules

Researchers search databases of known compounds to find molecules that might fit the pocket. They look at what’s already been tested, analyze structure-activity relationships, and identify promising starting points.

OpenDDE: ChEMBL ligand intelligence
4

Predict how drugs bind

Before testing in a lab, computational tools predict how a drug molecule will sit inside the pocket — its orientation, molecular contacts, and binding stability.

OpenDDE: AlphaFold 3 complex prediction
5

Optimize and test

The best candidates are refined — modified to bind more tightly, be more selective, and have fewer side effects. Then they enter lab testing and eventually clinical trials.

OpenDDE: AI suggestions + druglikeness scoring

The Impact

Why computational drug design?

1000x
faster

AI predicts binding in seconds vs weeks of wet-lab experiments

Weeks
not years

Virtual screening replaces months of manual compound testing

Novel
targets

Discover pockets on previously "undruggable" proteins

“[IsoDDE] more than doubles the accuracy of the best existing method, AlphaFold 3, in predicting binding poses for drug-like molecules.”

— Isomorphic Labs, February 2025

OpenDDE brings these capabilities to every researcher, for free, using open-source tools. No cloud GPU required. No vendor lock-in. Just science.

Platform

See OpenDDE in action

opendde.org/app/target/P00533
EGFR (P00533) — 3 druggable pockets detected
Pocket discovery

Pocket discovery

Enter any protein target and instantly see predicted binding pockets ranked by druggability. P2Rank’s ML algorithm identifies sites that traditional methods might miss — including allosteric and cryptic pockets.

Druggability scoring3D visualizationResidue mapping
View on GitHub

Demo

See it end to end

A guided walkthrough of the full OpenDDE pipeline — from target search to druggable insights — using real screenshots from the running app.

opendde.org/app/dashboard
1. Search a protein target
1. Search a protein target
Start from the dashboard and jump to any UniProt ID — EGFR, BRAF, ACE2, or your own.
1 / 5

Use Cases

Who is OpenDDE for?

🔬

Academic researchers

Explore new drug targets for your research. Identify druggable pockets, find known compounds, and generate publication-ready druggability reports — all without commercial software licenses.

Explore targets
💊

Pharma scientists

Rapidly screen targets and validate druggability before committing lab resources. Compare pockets, analyze structure-activity relationships, and prioritize compounds computationally.

Start screening
🎓

Students

Learn drug design concepts hands-on. Understand how binding pockets, ligand activity, and molecular predictions work in practice with real protein targets and compounds.

Start learning
🧬

Biotech startups

Professional-grade target assessment without expensive commercial software. Generate investor-ready druggability reports with pocket analysis, ligand landscape, and AI-powered insights.

Assess targets

Our mission

Open source and free forever

We believe computational drug design should be accessible to every researcher, not locked behind expensive licenses or proprietary platforms.

📜

MIT Licensed

Use, modify, and distribute freely. No strings attached, no usage limits, no hidden fees.

🐳

Docker Ready

One command to run everything. Six containers, fully orchestrated, with health checks and auto-restart.

🤝

Community Driven

Built in the open. Every feature request, bug report, and pull request makes the platform better for everyone.

Standing on shoulders

Inspired by the frontier

OpenDDE draws deep inspiration from Isomorphic Labs' IsoDDE, which demonstrated that AI-first drug design can more than double the accuracy of existing methods in predicting binding poses. While IsoDDE remains a proprietary, frontier system, OpenDDE aims to bring similar workflows to the open-source community by composing the best freely available tools into a cohesive, Docker-native platform.

OpenDDE is an independent, community-built project and is not affiliated with Isomorphic Labs or Google DeepMind. Its modular architecture allows each component to be swapped as better open-source alternatives emerge.

Everything you need for drug design

From target identification to lead optimization, OpenDDE provides a complete computational drug design workflow.

Pocket Discovery

Machine-learning binding site prediction with P2Rank. Identifies druggable pockets with residue-level detail.

Ligand Intelligence

Fetch known drugs from ChEMBL with IC50, Ki activity data, clinical phase, and structure-activity relationships.

Complex Prediction

Generate AlphaFold 3 input for protein-ligand binding. Semi-automated prediction workflow.

Antibody Modeling

Predict antibody 3D structures from VH/VL sequences using ABodyBuilder2 with CDR visualization.

AI Assistant

Claude-powered drug design insights. Context-aware analysis of targets, pockets, and ligands.

Analytics & Reports

Druggability reports, SAR plots, activity cliffs, pocket comparison, and PDF export.

Ready to explore?

Search any protein target and discover its druggable pockets, known compounds, and binding predictions in minutes.